Practice
Featured experience
Qorvo $22 billion combination with Skyworks Solutions
We are advising Qorvo on the transaction
Goldman Sachs $9.5 billion sale of Boyd Thermal and related business separations
We are advising Goldman Sachs Merchant Banking Division and its portfolio company Boyd on the transactions
AkzoNobel $25 billion merger of equals with Axalta Coating Systems
We are advising AkzoNobel on the transaction
REV Group $9 billion merger with Terex
We are advising REV Group on the transaction
ASMedia Technology $390 million acquisition of Techpoint
We are advising ASMedia on the transaction
Trustar Capital participation in proposed acquisition of Energy Monster
We advised Trustar Capital as a consortium member
Rokt $300 million merger with mParticle
We are advising Rokt on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Big Lots sale of substantially all of its assets to Gordon Brothers Retail Partners
We advised Big Lots on the sale
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction